SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending after Elon Musk's recent purchase of $1 billion in TSLA stock, signaling confidence and sparking a short squeeze. The community is debating whether this is a long-term bullish signal or a short-term pump before a potential correction, especially given concerns about sales and expiring EV credits. Broader discussions include Tesla's potential beyond EVs, focusing on energy storage, robotics, and AI, while some remain skeptical, drawing comparisons to past market bubbles.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Asset Entities Inc.

Asset Entities Inc. is trending due to its recent merger with Strive and a planned pivot towards Bitcoin asset management, creating excitement around a potential short squeeze. Some platforms are experiencing trading halts due to the CUSIP change, while community members debate holding strategies amidst high short interest and borrow fees. The stock's association with figures like Vivek Ramaswamy is also fueling speculation and interest.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

Anticipation is building around ATYR as traders await the release of Phase 3 trial data, expected mid-September, with the community buzzing about potential data leaks and speculating on the timing of the results. Community members are weighing bullish and bearish perspectives, debating the likelihood of trial success, and analyzing the potential for a short squeeze. With a binary event on the horizon, ATYR is seeing increased volatility and high options premiums, driving significant conversation among investors.

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is trending due to a recent surge following positive trial results for its stroke therapy, with community members debating whether to hold for a potential FDA submission catalyst or take profits amidst concerns of manipulation and past reverse splits. The stock's low float is fueling discussions about a potential short squeeze, while some caution against a possible offering. The community is closely watching for news that could drive the price higher, as well as the company's next move.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as the community rallies around its potential as the top meme coin on the Bitcoin network, emphasizing its fair launch and strong community. Discussions highlight the token's unique position within the Bitcoin ecosystem and the potential impact of increased visibility. Some community members also point to a partnership with $CBLO, which has been accumulating $DOG.X in its corporate treasury, as a key factor.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to Needham's raised price target and overall excitement in the quantum computing sector, sparking discussions about its potential and possible acquisitions. Community members debate the company's valuation, long-term prospects, and potential to become the "next NVDA", while also discussing upcoming catalysts like the analyst day and potential government contracts. The stock's breakout and trading volume are also contributing to the increased attention.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies behind the project's resilience and upcoming developments, including a Bifinance listing and airdrop. Community members highlight the project's organic growth, transparency, and active development team. Bullish sentiment is high, with many anticipating new ATHs and increased exposure for this Solana-based token.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as retail investors anticipate new peaks, with community members actively discussing potential price movements and key resistance levels. The stock is also gaining attention due to its participation in the White House's eVTOL pilot program and speculation around defense contracts. Community sentiment suggests anticipation for a potential squeeze, with some expressing frustration over the stock's performance compared to sector peers.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors discuss the potential impact of a recent real-world tragedy, with some speculating it could drive increased traffic to the platform amid broader conversations around free speech. Community members are also weighing in on the company's fundamentals, potential catalysts like the upcoming wallet launch, and the proposed acquisition of Northern Data. Additionally, there's discussion around the high short interest and its potential to fuel a squeeze.

Investment Managers Series Trust II - Tradr 2X Short TSLA Daily ETF

Tradr 2X Short TSLA Daily ETF

TSLQ is trending as traders react to Elon Musk's increased stake in Tesla and a potential feud with Donald Trump, leading to speculation about the stock's future direction. Community members are actively discussing swing trading strategies, entry points, and whether to capitalize on potential downturns or rallies in Tesla's price. Some traders express concerns about Tesla's valuation and potential impacts from expiring tax credits, while others remain optimistic about quick gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYBN  Cybin’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating 
 
TODAY, Sept 12, 2025, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Cybin, with a price target of $150.00. 
 
Patrick Trucchio has given his Buy rating due to a combination of factors that highlight Cybin’s promising advancements in their clinical programs.  
 
The company is making steady progress with its late-stage programs, particularly with CYB004 and CYB003. CYB004 has completed Phase 2a enrollment and is expected to release top-line data in the first quarter of 2026, which could significantly influence investor perception of their DMT programs.  
 
Additionally, CYB003 is advancing through the Phase 3 PARADIGM program for major depressive disorder under Breakthrough Therapy Designation, which allows for close FDA engagement 
 
https://www.tipranks.com/news/ratings/cybins-promising-clinical-advancements-and-strategic-positioning-justify-buy-rating-ratings

johni rotten

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Cybin, with a price target of $150.00. Patrick Trucchio has given his B...

TipRanks Financial

Cybin's Promising Clinical Advancements and Strategic Positioning Justify Buy Rating - TipRanks.com

StockTwits Web

Cybin Inc

  Cybin’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating 
 
TODAY, Sept 12, 2025, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Cybin, with a price target of $150.00. 
 
Patrick Trucchio has given his Buy rating due to a combination of factors that highlight Cybin’s promising advancements in their clinical programs.  
 
The company is making steady progress with its late-stage programs, particularly with CYB004 and CYB003. CYB004 has completed Phase 2a enrollment and is expected to release top-line data in the first quarter of 2026, which could significantly influence investor perception of their DMT programs.  
 
Additionally, CYB003 is advancing through the Phase 3 PARADIGM program for major depressive disorder under Breakthrough Therapy Designation, which allows for close FDA engagement 
 


Ken Robinson

@firetypecracker Glad to see you still have the conviction.

 Glad to see you still have the conviction.

@microdoseme Nothing has happened to make me change my mind. CEOs come and go; with or without explanations.  
 
The company&#39;s fundamentals and library of patented drugs have not changed. The clinical studies continue on with results on the horizon. And analysts keep the stock price targets just as high as before.   
 
Go Cybin Go!!!

Dennis

Anonyme

 Nothing has happened to make me change my mind. CEOs come and go; with or without explanations.  
 
The company's fundamentals and library of patented drugs have not changed. The clinical studies continue on with results on the horizon. And analysts keep the stock price targets just as high as before.   
 
Go Cybin Go!!!